Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes: Ingelheim, Germany Wednesday, November 13, 2024, 10:00 Hrs [IST] Boehringer Ingelheim and the ...
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the ...
Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.
Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...